Multimodality imaging in lobular breast cancer: Differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristics.

breast cancer invasive lobular breast cancer invasive lobular carcinoma (ILC) lobular breast cancer magnetic resonance imaging multimodality imaging

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 15 01 2022
accepted: 11 07 2022
entrez: 8 9 2022
pubmed: 9 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

Invasive lobular breast cancer (ILC) is a diagnostic challenge due to the diversity of morphological features. The objective of the study was to investigate the presentation and local extent of ILC using various imaging techniques and to assess the correlation between imaging and molecular profile. We reviewed 162 consecutive patients with ILC found on vacuum-assisted biopsy, who underwent evaluation of the lesion morphology and extent using ultrasound (US), mammography (MMG), and magnetic resonance imaging (MRI). Radiographic features were compared with ILC intrinsic subtype based on the expression of Ki-67 and estrogen, progesterone, and HER2 receptors. A total of 113 mass lesions and 49 non-mass enhancements (NMEs) were found in MRI. Masses were typically irregular and spiculated, showing heterogeneous contrast enhancement, diffusion restriction, and type III enhancement curve. NMEs presented mainly as the area of focal or multiregional distribution with heterogeneous or clumped contrast enhancement, diffusion restriction, and type III enhancement curve. Lesion extent significantly varied between MRI and MMG/ultrasonography (USG) (P < 0.001) but did not differ between MGF and ultrasonography (USG). The larger the ILC, the higher the disproportion when lesion extent in MRI was compared with MMG (P < 0.001) and ultrasonography (USG) (P < 0.001). In the study group, there were 97 cases of luminal A subtype (59.9%), 54 cases of luminal B HER2- (33.3%), nine cases of luminal B HER2+ (5.5%), and two cases of triple negative (1.2%). The HER2 type was not found in the study group. We did not observe any significant correlation between molecular profile and imaging. MRI is the most effective technique for the assessment of ILC local extent, which is important for optimal treatment planning. Further studies are needed to investigate if the intrinsic subtype of ILC can be predicted by imaging features on MRI.

Identifiants

pubmed: 36072800
doi: 10.3389/fonc.2022.855519
pmc: PMC9441946
doi:

Types de publication

Journal Article

Langues

eng

Pagination

855519

Informations de copyright

Copyright © 2022 Dołęga-Kozierowski, Lis, Marszalska-Jacak, Koziej, Celer, Bandyk, Kasprzak, Szynglarewicz and Matkowski.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Radiology. 1992 Dec;185(3):705-8
pubmed: 1438749
J Magn Reson Imaging. 2019 Sep;50(3):836-846
pubmed: 30811717
J Radiol. 2005 Sep;86(9 Pt 1):1027-34
pubmed: 16224343
Breast J. 2003 Jan-Feb;9(1):13-8
pubmed: 12558665
Breast Cancer Res. 2004;6(3):R149-56
pubmed: 15084238
Gland Surg. 2017 Aug;6(4):330-335
pubmed: 28861372
AJR Am J Roentgenol. 2002 May;178(5):1227-32
pubmed: 11959737
Radiographics. 2009 Jan-Feb;29(1):165-76
pubmed: 19168843
Cir Esp (Engl Ed). 2019 Aug - Sep;97(7):391-396
pubmed: 31186117
AJR Am J Roentgenol. 2013 Nov;201(5):W662-70
pubmed: 24147494
J Magn Reson Imaging. 2011 Jan;33(1):102-9
pubmed: 21182127
Eur Radiol. 2010 May;20(5):1111-7
pubmed: 19898850
Oncologist. 2009 Apr;14(4):320-68
pubmed: 19346299
Breast Cancer Res. 2019 Dec 4;21(1):136
pubmed: 31801635
AJR Am J Roentgenol. 1989 Aug;153(2):265-71
pubmed: 2750609
AJR Am J Roentgenol. 2009 Feb;192(2):379-83
pubmed: 19155397
Insights Imaging. 2014 Apr;5(2):183-94
pubmed: 24633840
J Comput Assist Tomogr. 2010 Jul;34(4):587-95
pubmed: 20657229
Breast Cancer Res Treat. 2008 Jan;107(1):1-14
pubmed: 18043894
Ultraschall Med. 2019 Dec;40(6):764-770
pubmed: 30253431
Radiology. 2011 Jul;260(1):50-60
pubmed: 21493794
Biomed Res Int. 2018 Jun 26;2018:1569060
pubmed: 30046588
Radiology. 1995 Apr;195(1):231-4
pubmed: 7892476
Breast J. 2017 Jul;23(4):421-428
pubmed: 28067435
Ultrasound Med Biol. 2005 Feb;31(2):167-74
pubmed: 15708454
Br J Radiol. 2018 Apr;91(1084):20170705
pubmed: 29299933
J Med Imaging Radiat Oncol. 2014 Feb;58(1):1-10
pubmed: 24529050
Breast. 2007 Dec;16 Suppl 2:S34-44
pubmed: 17959382
Int J Clin Exp Pathol. 2010 Feb 22;3(3):303-9
pubmed: 20224728
Can Assoc Radiol J. 2016 Aug;67(3):263-76
pubmed: 27038644
Eur J Radiol. 2018 Nov;108:120-127
pubmed: 30396643
Front Oncol. 2021 Sep 16;11:628824
pubmed: 34604024
Gland Surg. 2019 Jun;8(3):237-241
pubmed: 31328102
AJR Am J Roentgenol. 1999 Feb;172(2):325-30
pubmed: 9930776
Clin Imaging. 2000 Nov-Dec;24(6):333-6
pubmed: 11368932
Radiology. 2004 Dec;233(3):830-49
pubmed: 15486214
AJR Am J Roentgenol. 1996 Dec;167(6):1415-9
pubmed: 8956569
Breast Cancer Res. 2015 Jul 11;17:94
pubmed: 26163296
Eur J Radiol. 2019 Apr;113:148-152
pubmed: 30927939
Radiology. 1991 Jan;178(1):149-54
pubmed: 1984294
AJR Am J Roentgenol. 1993 Nov;161(5):957-60
pubmed: 8273634
Ann Surg Oncol. 2010 Oct;17 Suppl 3:255-62
pubmed: 20853043
Breast Cancer Res Treat. 2004 Jul;86(1):31-7
pubmed: 15218359
BMC Cancer. 2016 Mar 25;16:248
pubmed: 27015895
Breast J. 2016 Jul;22(4):384-9
pubmed: 27265271
Womens Health (Lond). 2014 Sep;10(5):511-8
pubmed: 25335542
Eur Radiol. 2004 Jul;14(7):1209-16
pubmed: 15024602

Auteurs

Bartosz Dołęga-Kozierowski (B)

Breast Unit, Department of Breast Imaging, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.

Michał Lis (M)

Burn and Plastic Surgery Department, Ludwik Rydygier Memorial Specialized Hospital in Krakow, Krakow, Poland.

Hanna Marszalska-Jacak (H)

Breast Unit, Department of Breast Imaging, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.

Mateusz Koziej (M)

Department of Anatomy, Jagiellonian University Medical College, Krakow, Poland.

Marcin Celer (M)

Breast Unit, Department of Breast Imaging, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.

Małgorzata Bandyk (M)

Breast Unit, Department of Breast Imaging, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.

Piotr Kasprzak (P)

Breast Unit, Department of Breast Imaging, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.

Bartłomiej Szynglarewicz (B)

Breast Unit, Department of Breast Surgery, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.

Rafał Matkowski (R)

Breast Unit, Department of Breast Surgery, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.
Department of Oncology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.

Classifications MeSH